Delayed referral for liver transplant evaluation worsens outcomes in chronic liver disease patients requiring inpatient transplant evaluation.

Autor:	Cooper KM; Department of Medicine, UMass Chan Medical School, Worcester, MA 01605, United States. katherine.cooper@umassmed.edu., Colletta A; Department of Medicine, UMass Chan Medical School, Worcester, MA 01605, United States., Hathaway NJ; Department of Medicine, UMass Chan Medical School, Worcester, MA 01605, United States., Liu D; Department of Medicine, UMass Chan Medical School, Worcester, MA 01605, United States., Gonzalez D; Department of Medicine, UMass Chan Medical School, Worcester, MA 01605, United States., Talat A; Department of Medicine, Division of Gastroenterology, UMass Chan Medical School, Worcester, MA 01605, United States., Barry C; Department of Medicine, Division of Gastroenterology, UMass Chan Medical School, Worcester, MA 01605, United States., Krishnarao A; Department of Medicine, Division of Gastroenterology, UMass Chan Medical School, Worcester, MA 01605, United States., Mehta S; Department of Medicine, Division of Gastroenterology, UMass Chan Medical School, Worcester, MA 01605, United States., Movahedi B; Department of Surgery, Transplant Division, UMass Chan Medical School, Worcester, MA 01605, United States., Martins PN; Department of Surgery, Transplant Division, UMass Chan Medical School, Worcester, MA 01605, United States., Devuni D; Department of Medicine, Division of Gastroenterology, UMass Chan Medical School, Worcester, MA 01605, United States.
Jazyk:	angličtina
Zdroj:	World journal of transplantation [World J Transplant] 2023 Jun 18; Vol. 13 (4), pp. 169-182.
DOI:	10.5500/wjt.v13.i4.169
Abstrakt:	Background: Indications to refer patients with cirrhosis for liver transplant evaluation (LTE) include hepatic decompensation or a model for end stage liver disease (MELD-Na) score ≥ 15. Few studies have evaluated how delaying referral beyond these criteria affects patient outcomes. Aim: To evaluate clinical characteristics of patients undergoing inpatient LTE and to assess the effects of delayed LTE on patient outcomes (death, transplantation). Methods: This is a single center retrospective cohort study assessing all patients undergoing inpatient LTE ( n = 159) at a large quaternary care and liver transplant center between 10/23/2017-7/31/2021. Delayed referral was defined as having prior indication (decompensation, MELD-Na ≥ 15) for LTE without referral. Early referral was defined as referrals made within 3 mo of having an indication based on practice guidelines. Logistic regression and Cox Hazard Regression were used to evaluate the relationship between delayed referral and patient outcomes. Results: Many patients who require expedited inpatient LTE had delayed referrals. Misconceptions regarding transplant candidacy were a leading cause of delayed referral. Ultimately, delayed referrals negatively affected overall patient outcome and an independent predictor of both death and not receiving a transplant. Delayed referral was associated with a 2.5 hazard risk of death. Conclusion: Beyond initial access to an liver transplant (LT) center, delaying LTE increases risk of death and reduces risk of LT in patients with chronic liver disease. There is substantial opportunity to increase the percentage of patients undergoing LTE when first clinically indicated. It is crucial for providers to remain informed about the latest guidelines on liver transplant candidacy and the transplant referral process. Competing Interests: Conflict-of-interest statement: All authors have no conflicts of interest related to this study to report. (©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu